Related Experiment Videos
Key considerations when reviewing subsequent primary cancers following radiotherapy - Authors' reply
Osama Mohamad1, Takahiro Tabuchi2, Toshitaka Morishima2
1National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
The Lancet. Oncology
|June 5, 2019
Abstract
No abstract available in PubMed .